APA (7th ed.) Citation

Busonero, C., Leone, S., Bianchi, F., & Acconcia, F. (2018). In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells. Cellular Oncology (2211-3428), 41(6), 677. https://doi.org/10.1007/s13402-018-0400-x

Chicago Style (17th ed.) Citation

Busonero, Claudia, Stefano Leone, Fabrizio Bianchi, and Filippo Acconcia. "In Silico Screening for ERα Down Modulators Identifies Thioridazine as an Anti-proliferative Agent in Primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing Breast Cancer Cells." Cellular Oncology (2211-3428) 41, no. 6 (2018): 677. https://doi.org/10.1007/s13402-018-0400-x.

MLA (9th ed.) Citation

Busonero, Claudia, et al. "In Silico Screening for ERα Down Modulators Identifies Thioridazine as an Anti-proliferative Agent in Primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing Breast Cancer Cells." Cellular Oncology (2211-3428), vol. 41, no. 6, 2018, p. 677, https://doi.org/10.1007/s13402-018-0400-x.